Insider Trading & Ownership of Jeffrey B. Kindler

Location
Allegan, MI
Summary
The estimated net worth of Jeffrey B. Kindler is at least $1,568,925 dollars as of 05 May 2026. Jeffrey B. Kindler is the Director of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $958K. Jeffrey B. Kindler is the Director of Praxis Precision Medicines, Inc. and owns shares of Praxis Precision Medicines, Inc. (PRAX) stock worth about $336.3K. Jeffrey B. Kindler is the Director of PERRIGO Co plc and owns shares of PERRIGO Co plc (PRGO) stock worth about $274.6K.
Signature
/s/ David Strauss, as Attorney-in-Fact for Jeffrey B Kindler
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jeffrey B. Kindler and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Jeffrey B. Kindler has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,568,925.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: PRECIGEN, INC. ($957,954).
  • Past-year value change for that position: -$1,460,091.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jeffrey B. Kindler

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PGEN PRECIGEN, INC. Director $957,954 -$1,460,091 -60% 13 Mar 2026
PRAX Praxis Precision Medicines, Inc. Director $336,332 06 Feb 2026
PRGO PERRIGO Co plc Director $274,639 14 May 2025
PPD PPD, Inc. Director 08 Dec 2021
TERN Terns Pharmaceuticals, Inc. Director 05 May 2026

Insider Transactions Reported by Jeffrey B. Kindler:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .